TickerTain
TickerTain
NewsroomShortsPortfolioConvergence
NewsroomShortsPortfolioConvergence
←
▶ 0:00 · $HIMS · Hims Is About to Trigger the Biggest Healthcare Shift in 100 Years
episode briefing
Antonio Linares

Hims Is About to Trigger the Biggest Healthcare Shift in 100 Years

2025-12-15 · 3 company · 3 thematic
sentiment
3 bull0 bear0 neu
speakers
antonio linares

Antonio Linares runs a concentrated six-stock portfolio plus micro investments, focusing on 'singularity scalers' — companies with proprietary data moats that compound value via AI scaling laws. He bought Palantir at ~$7, held through 2022-2024 drawdowns, and teaches a course on modern value creation processes. His framework emphasizes betting early on extraordinary companies, holding forever, and learning from concentrated mistakes.

quote
“I have a massive degree of conviction on one idea. And that is that while the market sees Hims as a GLP-1 company, it's actually a trillion-dollar giant in the making. Labs positions Hims to bring peptides and precision medicine to the mas…”
—antonio linares
now playing · $HIMS
$HIMS···bullish· high· posantonio linares
Linares: HIMS is a trillion-dollar precision medicine platform, not just GLP-1
HIMS Labs combines proprietary peptide manufacturing with low-cost, high-frequency biomarker testing to create a data flywheel enabling personalized precision medicine at scale, m…
$PLTR···bullish· high· posantonio linares
Linares compares HIMS to Palantir at $7: misunderstood platform play
Just as Palantir was misunderstood as a consulting company but was actually a digital twin platform essential for enterprise AI, HIMS is misunderstood as a GLP-1/telehealth compan…
$GRAL···bullish· mediumantonio linares
HIMS invests in Grail for early cancer detection via liquid biopsy
HIMS invested in Grail to add multi-cancer early detection via blood-based DNA methylation analysis to its biomarker platform, enhancing the precision medicine data flywheel with…